Public Release: 

For patients with brain tumors, insurance status linked to differences in patient safety and quality of care

Findings explained by differences in patient and hospital characteristics, says study in neurosurgery

Wolters Kluwer Health

February 27, 2015 - Patients that are on Medicaid or uninsured have higher rates of reportable patient safety and quality of care issues during hospitalization for brain tumors, reports a study in the March issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Wolters Kluwer.

Not having private insurance is associated with higher rates of patient safety issues (PSIs) and hospital-acquired conditions (HACs)--leading to longer hospital stays and worse patient outcomes, according to the study by Dr. Kristopher G. Hooten and colleagues of University of Florida, Gainesville. Especially with reporting of these quality metrics under health care reform, the authors call for efforts to address disparities in quality of care for vulnerable patient populations.

Insurance Status Linked to Patient Safety and Quality of Care

Using a nationwide hospital care database, the researchers analyzed nearly 550,000 patients with brain tumors receiving hospital care between 2002 and 2011. About 44 percent of patients were on Medicare and 41 percent had private insurance. The remaining 15 percent were classified as Medicaid or "self-pay" (uninsured) patients.

Overall rates of reportable PSIs and HACs were highest for Medicare patients: 22.8 and 4.0 percent, respectively. Further analysis of the effects of insurance status excluded the Medicare group--because it was restricted to older adults, it wasn't comparable to the other groups.

The Medicaid/self-pay patients had more reportable quality problems than the privately insured patients. Patient safety issues were reported for 20.6 percent of Medicaid/self-pay patients, compared to 8.6 percent for those with private insurance. Hospital-acquired conditions were reported for 2.2 percent of the Medicaid/self-pay group versus 1.9 percent of the privately insured group.

There were several important differences in patient characteristics between groups--including the fact that Medicaid/self-pay patients had more accompanying medical problems and were more likely to be hospitalized on an emergency basis, compared to those with private insurance.

After adjustment for patient factors, the differences by insurance status remained significant. The increased rates of PSIs and HACs in the Medicaid/self-pay group were associated with more time in the hospital and an increased risk of poor outcomes, including in-hospital death.

Differences Explained by Adjustment for Patient and Hospital Factors

Medicaid/self-pay patients were also more likely to be treated at government-funded and teaching hospitals, and the percentage of such patients was highest in Southern states. Controlling for hospital factors, in addition to patient factors, explained the effects of insurance status on PSIs and HACs.

That suggests that the higher rates of quality problems aren't explained by insurance status itself, but rather by a complex mix of related factors--including differences in access to health care and prehospital treatment. Even though teaching hospitals treated more Medicaid/self-pay patients, their rates of PSIs and HACs were no higher than at non-teaching hospitals.

Under the Affordable Care Act, hospitals' reimbursement is tied to their performance on measures including PSIs and HACs. The new study shows that for patients with brain tumors, rates of reportable patient safety and care quality problems are higher for Medicaid and underinsured patients, and lead to worse patient outcomes. Similar disparities related to insurance status have been found in other groups of patients, such as those undergoing vascular or colorectal cancer surgery.

Further study is needed to evaluate possible measures to address HACs and PSIs in brain tumor patients--focusing on common events such as falls, pressure ulcers, and postoperative respiratory failure. Dr. Hooten and colleagues conclude, "With the implementation of the Patient Safety and Affordable Care Act, the cause of these factors should be studied prospectively to begin the process of improving quality metrics in vulnerable patient populations."

###

Click here to read Insurance Status Influences the Rates of Reportable Quality Metrics in Brain Tumor Patients: A Nationwide Inpatient Sample Study."

Article: "Insurance Status Influences the Rates of Reportable Quality Metrics in Brain Tumor Patients: A Nationwide Inpatient Sample Study" (doi: 10.1227/NEU.0000000000000594)

About Neurosurgery

Neurosurgery, the Official Journal of the Congress of Neurological Surgeons, is your most complete window to the contemporary field of neurosurgery. Members of the Congress and non-member subscribers receive 3,000 pages per year packed with the very latest science, technology, and medicine, not to mention full-text online access to the world's most complete, up-to-the-minute neurosurgery resource. For professionals aware of the rapid pace of developments in the field, Neurosurgery is nothing short of indispensable.

About Wolters Kluwer Health

Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries worldwide, clinicians rely on Wolters Kluwer Health's market leading information-enabled tools and software solutions throughout their professional careers from training to research to practice. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.

Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2013 annual revenues of €3.6 billion ($4.7 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Follow our official Twitter handle: @WKHealth.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.